Patents by Inventor Kleanthis Xanthopoulos

Kleanthis Xanthopoulos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240374807
    Abstract: A computer-implemented method of monitoring an intracranial pressure using a fluid exchange system. The method includes receiving, at a processor, a first pressure value in an intracranial cavity; infusing a liquid into the intracranial cavity; receiving, at the processor, a second pressure value of the intracranial cavity; computing, using the processor, a difference between the first and second intracranial pressures; and in an event the difference between the first and second intracranial pressures exceeds a first pressure threshold value or is less than a second pressure threshold value, issuing a pressure signal output, via the processor, to indicate the first pressure threshold value has been exceeded or the difference between the first and second intracranial pressures is less than the second pressure threshold value.
    Type: Application
    Filed: June 18, 2024
    Publication date: November 14, 2024
    Inventors: Christos Panotopoulos, Lance Boling, Tim Kovac, Kleanthis Xanthopoulos
  • Patent number: 12042597
    Abstract: A fluid exchange system may include a control unit comprising a processor; a tube set attachment removably connected to the control unit, the tube set attachment comprising a tube set fluidly connected to a fluid source and a drainage receptacle; a catheter fluidly connected to the tube set; and at least one sensor positioned on at least one of the control unit and the tube set attachment, wherein the control unit may be configured to supply fluid to a patient through the tube set and drain fluid from the patient via the tube set, and wherein the control unit may be configured to receive measurements from the at least one sensor to adjust the supply of the fluid to the patient and the drainage of the fluid from the patient.
    Type: Grant
    Filed: March 19, 2018
    Date of Patent: July 23, 2024
    Assignee: IRRAS USA, Inc.
    Inventors: Christos Panotopoulos, Lance Boling, Tim Kovac, Kleanthis Xanthopoulos
  • Publication number: 20200237977
    Abstract: A fluid exchange system may include a control unit comprising a processor; a tube set attachment removably connected to the control unit, the tube set attachment comprising a tube set fluidly connected to a fluid source and a drainage receptacle; a catheter fluidly connected to the tube set; and at least one sensor positioned on at least one of the control unit and the tube set attachment, wherein the control unit may be configured to supply fluid to a patient through the tube set and drain fluid from the patient via the tube set, and wherein the control unit may be configured to receive measurements from the at least one sensor to adjust the supply of the fluid to the patient and the drainage of the fluid from the patient.
    Type: Application
    Filed: March 19, 2018
    Publication date: July 30, 2020
    Inventors: Christos Panotopoulos, Lance Boling, Timothy Kovac, Kleanthis Xanthopoulos
  • Patent number: 6489167
    Abstract: This invention provides a Togavirus-amplified retrovirus vector and a novel method for packaging a retrovirus cassette that contains a heterologous nucleic acid, which is amplified in a packaging cell cytoplasm by a Togavirus vector. The retroviral cassette is packaged into infectious retrovirus particles by retroviral packaging cells. These retroviral particles carrying the retroviral packaging cassette are then used to infect host cells.
    Type: Grant
    Filed: July 12, 1999
    Date of Patent: December 3, 2002
    Assignee: The Government of the United States as represented by the Secretary of the Department of Human Services
    Inventors: Richard Morgan, Jarmo Wahlfors, Kleanthis Xanthopoulos
  • Publication number: 20020025940
    Abstract: The invention provides for methods and compositions for identifying proteins or chemicals that directly or indirectly modulate a genomic polynucleotide and methods for identifying active genomic polynucleotides. Generally, the method comprises inserting an adeno-associated virus derived expression construct having a reporter gene into an eukaryotic genome, usually non-yeast, contained in at least one living cell, contacting the cell with a predetermined concentration of a modulator, and detecting reporter gene expression in the cell.
    Type: Application
    Filed: January 26, 2001
    Publication date: February 28, 2002
    Applicant: Aurora Biosciences Corporation
    Inventors: Michael A. Whitney, Kleanthis Xanthopoulos, David Nelson, Paul Negulescu, Frank Craig, J. Gordon Foulkes